Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Salisbury, D M
Right arrow Articles by Miller, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salisbury, D M
Right arrow Articles by Miller, E
Related Collections
Right arrow Immunology
Right arrow Ethics
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 62:201-211 (2002)
© 2002 The British Council

Vaccine programmes and policies

D M Salisbury*, P C L Beverley{dagger} and E Miller{ddagger}

*Department of Health, London, UK
{dagger}The Edward Jenner Institute for Vaccine Research, Berkshire, UK
{ddagger}Immunisation Division, Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK

Management of an effective national vaccine strategy necessitates careful planning. In the face of budgetary constraints and the likely development of many new vaccines over the next few years, a rational choice of which vaccines to use and how best to use them will depend on first class disease surveillance, economic analysis of cost effectiveness and mathematical modelling to ensure optimal vaccine delivery. Effective immunisation programmes require strategic planning that integrates the outputs of these parameters with available health facilities with the least possible disruption. At the present time, the greatest threat to vaccination is resistance to continuing vaccination in the face of declining prevalence of many infectious diseases and heightened fears over vaccine safety. Re-assurance of the public that vaccines are safe demands effective detection of vaccine-related side-effects and rigorous investigation of any safety concerns.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Science CommunicationHome page
C. E. Clarke
A Question of Balance: The Autism-Vaccine Controversy in the British and American Elite Press
Science Communication, September 1, 2008; 30(1): 77 - 107.
[Abstract] [PDF]

Home page
 Health Aff (Millwood)Home page
D. M. Salisbury
Development Of Immunization Policy And Its Implementation In The United Kingdom
Health Aff., May 1, 2005; 24(3): 744 - 754.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.